Fundraising Fox
Mitsui Global Investment
Venture capitalMenlo Park · Pre-Seed–Late Stage · 12 people tracked
Also known as MITSUI & CO. GLOBAL INVESTMENT, INC. · Mitsui & Co. Global Investment, Inc. 東京支店
Find your way into Mitsui Global Investment
Sign up to see every warm intro you have to Mitsui Global Investment
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mitsui Global Investment team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The firm positions itself as an investor that goes beyond financial backing, actively guiding entrepreneurs with strong business plans and ambitious goals. It partners with exceptional teams reinventing industries to improve human welfare worldwide, and emphasizes involvement in local communities alongside a global growth orientation. The firm highlights portfolio companies that have overcome setbacks and market challenges to grow stronger.
Source: firm website, verified Oct 13, 2026.
Team · 12 people
from the firm's website & public directories
Kazufumi Nakamura is an Investment Director at MGI who focuses on biotech and life sciences, with particular interest in startups where genetics and genomics inform disease biology. He has over 15 years of healthcare and life sciences experience across business development, investment, entrepreneurship, and R&D, and previously co-founded a biotech accelerating innovation from Japanese academic institutions. Earlier he worked in business development and licensing at Santen Pharmaceuticals and held clinical development roles at Janssen Pharmaceuticals; he holds a B.S. in pharmaceutical science from Tokyo University of Science and is a licensed pharmacist in Japan.
Joined Mitsui Global Investment and E12 Ventures as a Principal in June 2024, focusing on early-stage climate and manufacturing technology investments and supporting corporate LP collaboration with startups. Previously spent over a decade at Mitsui & Co. across international trading, JV investments, and business development in consumer products and petrochemical/biochemical materials.
Principal at E12 Ventures supporting corporate LPs with a focus on fintech, digital health, and quantum computing. In a parallel role at Mitsui Global Investments he serves as a board observer for Pica8 and has been involved in direct investments including Rallybio, BioNova, and Ensem Therapeutics; previously an investment manager at Mitsui & Co. He holds an Economics degree from The University of Tokyo and the CFA designation.
Caroline helps source and evaluate deals at E12, focusing especially on digital health. She has been an investor at Mitsui Global Investment since 2010 and previously worked as a translator/interpreter at the NUMMI auto plant. She holds a BA in Japanese and Spanish from Stanford.
What they invest in
from 28 of 62 portfolio companiesBiotech ×13AI & Machine Learning ×8Deep Tech ×7Healthtech ×7Digital Health ×5Enterprise Software ×5Medical Devices ×5Data & Infrastructure ×4
HQs:United States×28Japan×2Canada×1
Who they back
founder profiles across 24 portfolio companiesFounding team size:solo founder×112 founders×83 founders×44+ founders×1
Where their founders studiedfrom 18 founders with education data
Tel Aviv University ×3International Space University ×2The Hebrew University of Jerusalem ×2
What their founders studiedfrom 18 founders with field-of-study data
Life Sciences ×6Computer Science ×4Business & Management ×3Engineering ×2Finance & Accounting ×2Medicine ×2Physics ×2
Where their founders worked beforefrom 19 founders with career history
Google ×2NASA Ames Research Center ×2
Investments · 62 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 12023 · 12021 · 12018 · 12017 · 12015 · 32014 · 22012 · 315 dated
Kaltura provides AI-powered video platforms for live and on-demand digital experiences that enable brands and organizations to engage audiences and achieve business goals.
AI & Machine LearningEnterprise SoftwareMedia & EntertainmentNew York, US
Ron Yekutiel(Founder)inShay David(Director)inEynav Azaria(Chief Product, Engineering and Marketing Officer)inNatan Israeli(Chief Customer and Commercial Officer)inMichal Tsur(Founder)in
Co-investors.406 VenturesAvalon Ventures Management, LlcLuminari CapitalNGP CapitalRuna CapitalSapphire Ventures+5 more
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)
Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsF-Prime CapitalPivotal Life SciencesSolasta Ventures+2 more
Valens develops high-performance connectivity chipsets that are embedded in devices to support digital and connectivity experiences.
Deep TechHardwareMobility & TransportationSemiconductors
Co-investors10DAmiti VenturesAviv Venture CapitalF4 VenturesMagenta Venture PartnersMagma Venture Partners+3 more
Biotech developing small-molecule therapies for respiratory, inflammatory and autoimmune diseases, acquired by Boehringer Ingelheim.
BiotechSan Mateo, US
Peter McWilliams(Executive Officer, Director)Kevin Bacon(Executive Officer, Director)in
BoardFred Middleton(Director)Masaji Matsuoka(Director)in
Biotechnology company developing blood-brain-barrier-penetrating recombinant protein therapies for CNS disorders; acquired by JCR Pharmaceuticals in 2020.
Ruben Boado(Founder)in
Co-investorsBoehringer Ingelheim Venture Fund
Israeli fabless semiconductor company making vehicle-to-everything (V2X) communication chipsets for connected and autonomous vehicles.
Co-investorsAmiti VenturesFraser McCombs CapitalMagenta Venture PartnersMagma Venture PartnersManiv MobilitySamsung Catalyst Fund+6 more
Ellipsis builds AI agents that handle repetitive engineering tasks like code review, production debugging, and standup reports, letting teams focus on higher-value work.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareNew York City, US
Hunter Brooks(CEO)inNick Bradford(CTO)
Co-investorsPioneerTranspose Platform ManagementY CombinatorAmino CapitalCRV (Charles River Ventures)Four Cities+5 more
-2.png)
Ellipsis Health builds Sage, an AI voice agent designed to support healthcare organizations by handling patient interactions and expanding clinical capacity.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Mainul Islam(Executive Officer, Director)Mainul Mondal(Founder)inMichael Aratow(Co-Founder & Chief Medical Officer)in
BoardMarie Hurabiell(Director)
Co-investorsAble PartnersAIX VenturesAlumni VenturesAwareness VentureCity LightCVS Health Ventures+10 more
GoSecure is a Managed Detection and Response (MDR) cybersecurity provider based in Montreal and San Diego.
San Diego, US
Co-investorsEastward Capital PartnersRazor's Edge VenturesShield CapitalYaletown Partners
Mahzi develops therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders, working with patient and family groups, academic researchers, and industry partners.
BiotechHealthtechSouth San Francisco, US
Yael Weiss(Chief Executive Officer)in
BoardCamille Samuels(Director)inMarten Steen(Director)inShalini Sharp(Director)inStephen Farr(Director)
Co-investorsDroia VenturesHBM Healthcare InvestmentsHBM PartnersHealthCapVenrock
Davis, California developer of biological crop protection, plant health and waterway treatment products, formerly NASDAQ: MBII.
AgTechDavis, US
Pamela G. Marrone(Executive Officer, Director)James B. Boyd(Executive Officer)Linda V. Moore(Executive Officer)inDon Glidewell(Executive Officer)inJulie I Morris(Executive Officer)inChris Hildreth(Executive Officer)in
Co-investorsBand of AngelsPoint Financial Capital
MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)
BoardMarc Singer(Director)in
Co-investorsBraemar Energy VenturesOUP (Osage University Partners)Windham Capital PartnersAberdare VenturesNorth Bridge Venture Partners & Growth Equity
Neura Health provides telemedicine video visits with board-certified neurologists for conditions including migraine, epilepsy, sleep disorders, tremor, concussion, and stroke.
Digital HealthHealthtechNew York, US
Sameer Madan(Founder)inElizabeth Burstein(Founder)in
Co-investorsCorrelation VenturesE12 Venture Capital, LlcEsplanade VenturesKoch Disruptive TechnologiesNext Play VenturesPear VC+4 more
OpenX is a supply-side platform (SSP) for digital advertising that uses AI, data leadership, and proprietary identity technology to manage ad inventory and targeting.
AdTechAI & Machine LearningNot specified on page, US
DAMON REEVE(Director)inTIM CADOGAN(Executive Officer, Director)inJoshua Metzger(Interim CEO)in
BoardNINO MARAKOVIC(Director)inANDREW Scott BRACCIA(Director)BERNARD DALLE(Director)in
Co-investorsChartline Capital PartnersDag VenturesIndex VenturesLocalGlobePresidio VenturesSapphire Ventures+7 more
Pica8 develops PICOS, a Linux-based open network operating system, and the AmpCon controller for white box enterprise networks.
Palo Alto, US
Chunyi (James) Liao(Executive Officer, Director)
BoardTerry Chen(Director)inChen-Wen Tarn(Director)Mike Splinter(Director)
Co-investorsVantagePoint Capital PartnersWI Harper Group
ProteinSimple developed instruments and consumables for protein analysis; acquired by Techne/Bio-Techne for $300M in 2014.
Co-investorsLatterell Venture PartnersThe Vertical Group
Proterra designs and manufactures zero-emission battery systems for commercial vehicles.
CleantechHardwareMobility & TransportationGreenville, US
Ryan Popple(Executive Officer, Director)Eric McCarthy(Executive Officer)C. W. Plummer, Jr.(Executive Officer)Dave Rich(Executive Officer)Christopher BaileyinDale Hill(Founder)
Co-investorsBMW i VenturesConductive VenturesConstellation Technology VenturesEnergy Impact PartnersEvolution VC PartnersObvious Ventures+6 more
QD Laser develops, manufactures, and sells high-efficiency semiconductor lasers for telecommunications and industrial use, as well as visual-information devices.
Deep TechHardwareMedical DevicesSemiconductorsYokohama, JP
Mitsuru Sugawara(Founder)in菅原 充(Founder & Chief Technology Advisor)大久保 潔(President & Representative Director)
Co-investorsBeyond Next VenturesDG Ventures, Inc.MIRAI SOUZOUNTT DOCOMO VenturesOita Venture CapitalSMBC Venture Capital+5 more
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more
Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.
BiotechDigital HealthMental HealthMorristown, US
Sahil V. Kirpekar(President and CEO)inGregory Mayes(Executive Officer, Director)Ellen Lubman(Director)Mark Pollack(Executive Officer)inNathan Bryson(Executive Officer)inMark Theeuwes(Executive Officer)in
Co-investorsFemHealth VenturesMPM BioImpactPalo Santo VCNovo Holdings
Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareAlexandria, US
Adam Branch(Executive Officer, Director, Promoter)in
BoardHarrison Touati(Director)Jon Galitzer(Director)
Co-investorsKoch Disruptive TechnologiesLionBirdAlleyCorpArkin Digital HealthGaingelsJLL Spark Global Ventures+3 more
__Twitter.png)
Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.
AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US
Ittai Dayan(Dr.)inYuval Baror(Founder)inChristopher Laws(Executive Officer)
BoardEdward Michael(Director)inIvneet Bhullar(Director)in
Co-investorsAlleyCorpE12 Venture Capital, LlcFusionLionBirdMana VenturesQiming Venture Partners USA+6 more
Monmouth Junction, US
David C. Aldous(Executive Officer, Director)in
BoardWilliam Wiberg(Director)Jamie Kiggen(Director)Daniel Carter(Director)inMichael Zak(Director)David J. Tippeconnic(Director)
Co-investorsAramco VenturesSaudi Aramco Energy VenturesThe Blackstone Group
JS Communications provides network integration services, infrastructure solutions, and security technologies for enterprise IT systems.
Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareIoTTokyo, JP
William Kish(Executive Officer, Director)Victor Shtrom(Executive Officer)Selina Lo(Executive Officer, Director)James Hennessy(Executive Officer)愛須 康之(代表取締役会長 (Representative Director & Chairman))渡邉 辰夫(代表取締役社長 (Representative Director & President))
Co-investorsMobile Internet Capital, Inc.WingSequoia CapitalSutter Hill Ventures
Sirrus develops chemical building blocks based on patented methylene malonate monomers and oligomeric crosslinkers that polymerize anionically at ambient temperatures.
Advanced ManufacturingCleantechDeep TechNew MaterialsLoveland, US
Bernard Malofsky(Executive Officer)inJeff Uhrig(President, Chief Executive Officer, Secretary and Treasurer)inRobert Smith(Executive Officer)Adam Malofsky(Director)
BoardWilliam Lese(Director)inDoug Cameron(Director)
Co-investorsBraemar Energy VenturesCincyTechArsenal
Spire operates a constellation of nanosatellites that collect granular Earth and environmental data from orbit, providing analytics for climate, logistics, and community protection.
Climate TechData & InfrastructureLogistics & Supply ChainSpace TechVienna, Virginia, US
Peter Platzer(Executive Chairman)inJeroen Cappaert(Founder)inJoel Spark(Founder)inTheresa Condor(Chief Executive Officer)inCelia Perez Pelaz(Executive Officer)Thomas Krywe(Executive Officer)in
Co-investorsBessemer Venture PartnersBright Success CapitalEvolution VC PartnersExpon CapitalFresco CapitalGen Capital+12 more
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)
Co-investorsAIX VenturesFoothill VenturesAxial VCBoxOne VenturesCaffeinated CapitalDimension Capital+1 more
Svante builds filters and modular rotary contactor machines that capture and remove CO2 from industrial emissions and directly from the air.
CleantechClimate TechDeep TechEnergyNew MaterialsBurnaby, CA
Matthew Stevenson(Executive Officer)inClaude Letourneau(President & CEO)
BoardMarc Van Den Berg(Director)Roger Strauch(Director)inDamien Vacherot(Director)Laura Boudreau(Director)
Co-investorsChrysalixThe Roda GroupChevron Technology VenturesMitsui & CoTemasekBay Bridge Ventures Climate+7 more
Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.
BiotechDeep TechHealthtechSan Francisco, US
Co-investorsCivilization Ventures Management, LlcEisai Innovation, Inc.Laurier Startup FundKdT VenturesMichigan Capital Network
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsAngelini VenturesDementia Discovery FundDolby Family Ventures+2 more
Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
AI & Machine LearningBiotechDeep TechNew York, US
Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in
Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMBX CapitalRecode VenturesVillage Global+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ActimisArmaGenBeceemBioelectron Technology CorpBionova Pharmaceuticals LimitedBoston Biomedical IncChange Healthcare CorpCipiaContinuumrx ServicesConvenient Power LimitedEnsemEtonenet IncGladd Inc Fka Glamour Sales Holding LtdGobalto IncHainan Hailing Pharmaceutical LimitedHalationIat Automobile TechnologyLeash LaboratoriesLeyou IncNapaJen Pharma, Inc.NvascNxthera IncOn Chip BiotechnologiesPinnacle EnginesRedwood Systems IncS*BIOSbio Pte LtdSilk Fka Kaminario IncSix Rooms HoldingsSymic BiomedicalVirident
Exits · 29
6 IPOs · 23 acquisitions · showing 5KalturaNASDAQ: KLTRRallybio, LLCNASDAQ: RLYBValens (NYSE: VLN)NYSE: VLNMC10acq. by MedidataRedwood Systems Incacq. by CommScope
Portfolio news
latest coverage across their companiesWaypoint Bio · finsmes.com · Jun 2, 2026
OpenX · openx.com · Jan 14, 2026
Stately Bio · finsmes.com · May 1, 2025
Frequently asked questions
- How many investments has Mitsui Global Investment made?
- Mitsui Global Investment has 62 tracked investments, 29 of which have exited, including 3 dated in the last 24 months.
- What stage does Mitsui Global Investment invest at?
- Mitsui Global Investment invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Mitsui Global Investment's typical check size?
- Mitsui Global Investment typically writes checks of $500K – $10M.
- What sectors does Mitsui Global Investment focus on?
- Mitsui Global Investment focuses on AI & Machine Learning, Biotech, Cleantech, Consumer, Data & Infrastructure, Energy, Enterprise Software, FoodTech, Hardware, Healthtech, Medical Devices, New Materials, SaaS, Sector Agnostic, Semiconductors.
- Where is Mitsui Global Investment located?
- Mitsui Global Investment is headquartered in Menlo Park, US.
- Who does Mitsui Global Investment co-invest with?
- Mitsui Global Investment most often shares deals with Dolby Family Ventures, E12 Venture Capital, Llc, Magma Venture Partners, among 131 tracked co-investors.
Images
Similar investors
Chuangdongfang (创东方) is a Shenzhen-based investment firm focused on equity investment in technology and innovation-driven enterprises, engaging in venture, M&A, and industrial investment.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Oost NL is a regional development agency that supports and connects innovative entrepreneurs in the Dutch provinces of Gelderland and Overijssel, helping accelerate technological innovation through capital, network, and knowledge.